메뉴 건너뛰기




Volumn 122, Issue , 2014, Pages 173-189

The experimental autoimmune encephalomyelitis (EAE) model of MS. utility for understanding disease pathophysiology and treatment.

Author keywords

Epitope spreading; Experimental autoimmune encephalomyelitis; Immune tolerance; Immunotherapy; Regulatory T cells; Th1 Th17

Indexed keywords

EPITOPE;

EID: 84893454390     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52001-2.00008-X     Document Type: Chapter
Times cited : (356)

References (193)
  • 1
    • 33646890625 scopus 로고    scopus 로고
    • Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis
    • Aboul-Enein F., Weiser P., Hoftberger R., et al. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol 2006, 111:539-547.
    • (2006) Acta Neuropathol , vol.111 , pp. 539-547
    • Aboul-Enein, F.1    Weiser, P.2    Hoftberger, R.3
  • 2
    • 0028828168 scopus 로고
    • The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
    • Adelmann M., Wood J., Benzel I., et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995, 63:17-27.
    • (1995) J Neuroimmunol , vol.63 , pp. 17-27
    • Adelmann, M.1    Wood, J.2    Benzel, I.3
  • 3
    • 0037449737 scopus 로고    scopus 로고
    • Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17
    • Aggarwal S., Ghilardi N., Xie M.H., et al. Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
    • (2003) J Biol Chem , vol.278 , pp. 1910-1914
    • Aggarwal, S.1    Ghilardi, N.2    Xie, M.H.3
  • 4
    • 30044451754 scopus 로고    scopus 로고
    • The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice
    • Aharoni R., Eilam R., Domev H., et al. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc Natl Acad Sci U S A 2005, 102:19045-19050.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 19045-19050
    • Aharoni, R.1    Eilam, R.2    Domev, H.3
  • 5
    • 49649090657 scopus 로고    scopus 로고
    • Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis
    • Aharoni R., Herschkovitz A., Eilam R., et al. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2008, 105:11358-11363.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 11358-11363
    • Aharoni, R.1    Herschkovitz, A.2    Eilam, R.3
  • 6
    • 0022995760 scopus 로고
    • Defective suppressor cell function mediated by T8+ cell line from patients with progressive multiple sclerosis
    • Antel J., Bania M., Avertano N., et al. Defective suppressor cell function mediated by T8+ cell line from patients with progressive multiple sclerosis. J Immunol 1986, 137:3436-3439.
    • (1986) J Immunol , vol.137 , pp. 3436-3439
    • Antel, J.1    Bania, M.2    Avertano, N.3
  • 7
    • 46049093364 scopus 로고    scopus 로고
    • Th17 Cells and autoimmune encephalomyelitis (EAE/MS)
    • Aranami T., Yamamura T. Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int 2008, 57:115-120.
    • (2008) Allergol Int , vol.57 , pp. 115-120
    • Aranami, T.1    Yamamura, T.2
  • 8
    • 77950534540 scopus 로고    scopus 로고
    • T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis
    • Axtell R.C., de Jong B.A., Boniface K., et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 2010, 16:406-412.
    • (2010) Nat Med , vol.16 , pp. 406-412
    • Axtell, R.C.1    de Jong, B.A.2    Boniface, K.3
  • 9
    • 0034618094 scopus 로고    scopus 로고
    • Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
    • Babbe H., Roers A., Waisman A., et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393-404.
    • (2000) J Exp Med , vol.192 , pp. 393-404
    • Babbe, H.1    Roers, A.2    Waisman, A.3
  • 10
    • 0031469731 scopus 로고    scopus 로고
    • Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA
    • Bai X.F., Shi F.D., Xiao B.G., et al. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA. J Neuroimmunol 1997, 80:65-75.
    • (1997) J Neuroimmunol , vol.80 , pp. 65-75
    • Bai, X.F.1    Shi, F.D.2    Xiao, B.G.3
  • 11
    • 34548443292 scopus 로고    scopus 로고
    • FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis
    • Balatoni B., Storch M.K., Swoboda E.M., et al. FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis. Brain Res Bull 2007, 74:307-316.
    • (2007) Brain Res Bull , vol.74 , pp. 307-316
    • Balatoni, B.1    Storch, M.K.2    Swoboda, E.M.3
  • 12
    • 84863803849 scopus 로고    scopus 로고
    • B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
    • Barr T.A., Shen P., Brown S., et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 2012, 209:1001-1010.
    • (2012) J Exp Med , vol.209 , pp. 1001-1010
    • Barr, T.A.1    Shen, P.2    Brown, S.3
  • 13
    • 0036677420 scopus 로고    scopus 로고
    • Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
    • Becher B., Durell B.G., Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 2002, 110:493-497.
    • (2002) J Clin Invest , vol.110 , pp. 493-497
    • Becher, B.1    Durell, B.G.2    Noelle, R.J.3
  • 14
    • 0347357773 scopus 로고    scopus 로고
    • IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis
    • Becher B., Durell B.G., Noelle R.J. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J Clin Invest 2003, 112:1186-1191.
    • (2003) J Clin Invest , vol.112 , pp. 1186-1191
    • Becher, B.1    Durell, B.G.2    Noelle, R.J.3
  • 15
    • 0029986881 scopus 로고    scopus 로고
    • The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease
    • Ben-Nun A., Mendel I., Bakimer R., et al. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease. J Neurol 1996, 243:S14-S22.
    • (1996) J Neurol , vol.243
    • Ben-Nun, A.1    Mendel, I.2    Bakimer, R.3
  • 16
    • 0033563260 scopus 로고    scopus 로고
    • Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis
    • Benson J.M., Stuckman S.S., Cox K.L., et al. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J Immunol 1999, 162:6247-6254.
    • (1999) J Immunol , vol.162 , pp. 6247-6254
    • Benson, J.M.1    Stuckman, S.S.2    Cox, K.L.3
  • 17
    • 0038790058 scopus 로고    scopus 로고
    • Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
    • Berger T., Rubner P., Schautzer F., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003, 349:139-145.
    • (2003) N Engl J Med , vol.349 , pp. 139-145
    • Berger, T.1    Rubner, P.2    Schautzer, F.3
  • 18
    • 3142724732 scopus 로고    scopus 로고
    • Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis
    • Bettelli E., Sullivan B., Szabo S.J., et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 2004, 200:79-87.
    • (2004) J Exp Med , vol.200 , pp. 79-87
    • Bettelli, E.1    Sullivan, B.2    Szabo, S.J.3
  • 19
    • 2942537826 scopus 로고    scopus 로고
    • Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta
    • Bielekova B., Richert N., Howard T., et al. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci U S A 2004, 101:8705-8708.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 8705-8708
    • Bielekova, B.1    Richert, N.2    Howard, T.3
  • 20
    • 33645812129 scopus 로고    scopus 로고
    • Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis
    • Bielekova B., Catalfamo M., Reichert-Scrivner S., et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 2006, 103:5941-5946.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 5941-5946
    • Bielekova, B.1    Catalfamo, M.2    Reichert-Scrivner, S.3
  • 21
    • 65249138318 scopus 로고    scopus 로고
    • Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis
    • Bielekova B., Howard T., Packer A.N., et al. Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch Neurol 2009, 66:483-489.
    • (2009) Arch Neurol , vol.66 , pp. 483-489
    • Bielekova, B.1    Howard, T.2    Packer, A.N.3
  • 22
    • 2942746494 scopus 로고    scopus 로고
    • A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response
    • Bischof F., Bins A., Durr M., et al. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response. J Immunol 2004, 173:600-606.
    • (2004) J Immunol , vol.173 , pp. 600-606
    • Bischof, F.1    Bins, A.2    Durr, M.3
  • 23
    • 0023927111 scopus 로고
    • Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
    • Bitar D.M., Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol 1988, 112:364-370.
    • (1988) Cell Immunol , vol.112 , pp. 364-370
    • Bitar, D.M.1    Whitacre, C.C.2
  • 24
    • 65949111512 scopus 로고    scopus 로고
    • Identification of human S100A9 as a novel target for treatment of autoimmune diseasevia binding to quinoline-3-carboxamides
    • Bjork P., Bjork A., Vogl T., et al. Identification of human S100A9 as a novel target for treatment of autoimmune diseasevia binding to quinoline-3-carboxamides. PLoS Biol 2009, 7:e97.
    • (2009) PLoS Biol , vol.7
    • Bjork, P.1    Bjork, A.2    Vogl, T.3
  • 25
    • 0017277853 scopus 로고
    • Biochemical findings in multiple sclerosis III Immunoglobulins of restricted heterogeneity and light chain distribution in cerebrospinal fluid of patients with multiple sclerosis
    • Bollengier F., Delmotte P., Lowenthal A. Biochemical findings in multiple sclerosis III Immunoglobulins of restricted heterogeneity and light chain distribution in cerebrospinal fluid of patients with multiple sclerosis. J Neurol 1976, 212:151-158.
    • (1976) J Neurol , vol.212 , pp. 151-158
    • Bollengier, F.1    Delmotte, P.2    Lowenthal, A.3
  • 26
    • 0021079164 scopus 로고
    • Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis
    • Booss J., Esiri M.M., Tourtellotte W.W., et al. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983, 62:219-232.
    • (1983) J Neurol Sci , vol.62 , pp. 219-232
    • Booss, J.1    Esiri, M.M.2    Tourtellotte, W.W.3
  • 27
    • 0036710356 scopus 로고    scopus 로고
    • The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis
    • Brunmark C., Runstrom A., Ohlsson L., et al. The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. J Neuroimmunol 2002, 130:163-172.
    • (2002) J Neuroimmunol , vol.130 , pp. 163-172
    • Brunmark, C.1    Runstrom, A.2    Ohlsson, L.3
  • 28
    • 0032902375 scopus 로고    scopus 로고
    • Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis
    • Burns J., Bartholomew B., Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol 1999, 45:33-39.
    • (1999) Ann Neurol , vol.45 , pp. 33-39
    • Burns, J.1    Bartholomew, B.2    Lobo, S.3
  • 29
    • 0032055153 scopus 로고    scopus 로고
    • Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis
    • Burt R.K., Padilla J., Begolka W.S., et al. Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood 1998, 91:2609-2616.
    • (1998) Blood , vol.91 , pp. 2609-2616
    • Burt, R.K.1    Padilla, J.2    Begolka, W.S.3
  • 30
    • 0028037782 scopus 로고
    • Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis
    • Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
    • (1994) Science , vol.265 , pp. 1237-1240
    • Chen, Y.1    Kuchroo, V.K.2    Inobe, J.3
  • 31
    • 33646433989 scopus 로고    scopus 로고
    • Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
    • Chen Y., Langrish C.L., McKenzie B., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006, 116:1317-1326.
    • (2006) J Clin Invest , vol.116 , pp. 1317-1326
    • Chen, Y.1    Langrish, C.L.2    McKenzie, B.3
  • 32
    • 0032882173 scopus 로고    scopus 로고
    • Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
    • Coles A.J., Wing M.G., Molyneux P., et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999, 46:296-304.
    • (1999) Ann Neurol , vol.46 , pp. 296-304
    • Coles, A.J.1    Wing, M.G.2    Molyneux, P.3
  • 33
    • 54949143968 scopus 로고    scopus 로고
    • Alemtuzumab vs interferon beta-1a in early multiple sclerosis
    • Coles A.J., Compston D.A., Selmaj K.W., et al. Alemtuzumab vs interferon beta-1a in early multiple sclerosis. N Engl J Med 2008, 359:1786-1801.
    • (2008) N Engl J Med , vol.359 , pp. 1786-1801
    • Coles, A.J.1    Compston, D.A.2    Selmaj, K.W.3
  • 34
    • 0032528896 scopus 로고    scopus 로고
    • Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy
    • Comabella M., Balashov K., Issazadeh S., et al. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest 1998, 102:671-678.
    • (1998) J Clin Invest , vol.102 , pp. 671-678
    • Comabella, M.1    Balashov, K.2    Issazadeh, S.3
  • 35
    • 41949135382 scopus 로고    scopus 로고
    • Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
    • Correale J., Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 2008, 195:121-134.
    • (2008) J Neuroimmunol , vol.195 , pp. 121-134
    • Correale, J.1    Villa, A.2
  • 36
    • 0028215537 scopus 로고
    • T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
    • Critchfield J.M., Racke M.K., Zuniga-Pflucker J.C., et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994, 263:1139-1143.
    • (1994) Science , vol.263 , pp. 1139-1143
    • Critchfield, J.M.1    Racke, M.K.2    Zuniga-Pflucker, J.C.3
  • 37
    • 0037434789 scopus 로고    scopus 로고
    • Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
    • Cua D.J., Sherlock J., Chen Y., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
    • (2003) Nature , vol.421 , pp. 744-748
    • Cua, D.J.1    Sherlock, J.2    Chen, Y.3
  • 38
    • 0027204621 scopus 로고
    • Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production
    • Del Prete G., De Carli M., Almerigogna F., et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993, 150:353-360.
    • (1993) J Immunol , vol.150 , pp. 353-360
    • Del Prete, G.1    De Carli, M.2    Almerigogna, F.3
  • 39
    • 0037408259 scopus 로고    scopus 로고
    • Glatiramer acetate (Copaxone) therapy for multiple sclerosis
    • Dhib-Jalbut S. Glatiramer acetate (Copaxone) therapy for multiple sclerosis. Pharmacol Ther 2003, 98:245-255.
    • (2003) Pharmacol Ther , vol.98 , pp. 245-255
    • Dhib-Jalbut, S.1
  • 40
    • 0033857977 scopus 로고    scopus 로고
    • Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice
    • Dittel B.N., Urbania T.H., Janeway C.A. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. J Autoimmun 2000, 14:311-318.
    • (2000) J Autoimmun , vol.14 , pp. 311-318
    • Dittel, B.N.1    Urbania, T.H.2    Janeway, C.A.3
  • 41
    • 33644817756 scopus 로고    scopus 로고
    • Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
    • Dutta R., McDonough J., Yin X., et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006, 59:478-489.
    • (2006) Ann Neurol , vol.59 , pp. 478-489
    • Dutta, R.1    McDonough, J.2    Yin, X.3
  • 42
    • 0345601517 scopus 로고    scopus 로고
    • Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group
    • Ebers G.C., Hommes O., Hughes R.A.C., et al. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 1998, 352:1498-1504.
    • (1998) Lancet , vol.352 , pp. 1498-1504
    • Ebers, G.C.1    Hommes, O.2    Hughes, R.A.C.3
  • 43
    • 0036795531 scopus 로고    scopus 로고
    • B cells regulate autoimmunity by provision of IL-10
    • Fillatreau S., Sweenie C.H., McGeachy M.J., et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
    • (2002) Nat Immunol , vol.3 , pp. 944-950
    • Fillatreau, S.1    Sweenie, C.H.2    McGeachy, M.J.3
  • 44
    • 35348970884 scopus 로고    scopus 로고
    • Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis
    • Foster C.A., Howard L.M., Schweitzer A., et al. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J Pharmacol Exp Ther 2007, 323:469-475.
    • (2007) J Pharmacol Exp Ther , vol.323 , pp. 469-475
    • Foster, C.A.1    Howard, L.M.2    Schweitzer, A.3
  • 45
    • 61649121740 scopus 로고    scopus 로고
    • FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage
    • Foster C.A., Mechtcheriakova D., Storch M.K., et al. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 2009, 19:254-266.
    • (2009) Brain Pathol , vol.19 , pp. 254-266
    • Foster, C.A.1    Mechtcheriakova, D.2    Storch, M.K.3
  • 46
    • 0030918326 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis
    • Frei K., Eugster H.P., Bopst M., et al. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1997, 185:2177-2182.
    • (1997) J Exp Med , vol.185 , pp. 2177-2182
    • Frei, K.1    Eugster, H.P.2    Bopst, M.3
  • 47
    • 55549104692 scopus 로고    scopus 로고
    • Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis
    • Friese M.A., Jakobsen K.B., Friis L., et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med 2008, 14:1227-1235.
    • (2008) Nat Med , vol.14 , pp. 1227-1235
    • Friese, M.A.1    Jakobsen, K.B.2    Friis, L.3
  • 48
    • 66549130329 scopus 로고    scopus 로고
    • The relation between inflammation and neurodegeneration in multiple sclerosis brains
    • Frischer J.M., Bramow S., Dal-Bianco A., et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132:1175-1189.
    • (2009) Brain , vol.132 , pp. 1175-1189
    • Frischer, J.M.1    Bramow, S.2    Dal-Bianco, A.3
  • 49
    • 0037379202 scopus 로고    scopus 로고
    • Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment
    • Fujino M., Funeshima N., Kitazawa Y., et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003, 305:70-77.
    • (2003) J Pharmacol Exp Ther , vol.305 , pp. 70-77
    • Fujino, M.1    Funeshima, N.2    Kitazawa, Y.3
  • 50
    • 0027056539 scopus 로고
    • Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy
    • Gaur A., Wiers B., Liu A., et al. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 1992, 258:1491-1494.
    • (1992) Science , vol.258 , pp. 1491-1494
    • Gaur, A.1    Wiers, B.2    Liu, A.3
  • 51
    • 84870953123 scopus 로고    scopus 로고
    • Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
    • Getts D.R., Martin A.J., McCarthy D.P., et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 2012, 30:1217-1224.
    • (2012) Nat Biotechnol , vol.30 , pp. 1217-1224
    • Getts, D.R.1    Martin, A.J.2    McCarthy, D.P.3
  • 52
    • 84866423965 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
    • Gold R., Kappos L., Arnold D.L., et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012, 367:1098-1107.
    • (2012) N Engl J Med , vol.367 , pp. 1098-1107
    • Gold, R.1    Kappos, L.2    Arnold, D.L.3
  • 53
    • 0141832116 scopus 로고    scopus 로고
    • Lymphotoxin/light, lymphoid microenvironments and autoimmune disease
    • Gommerman J.L., Browning J.L. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 2003, 3:642-655.
    • (2003) Nat Rev Immunol , vol.3 , pp. 642-655
    • Gommerman, J.L.1    Browning, J.L.2
  • 54
    • 84865261493 scopus 로고    scopus 로고
    • TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
    • Gregory A.P., Dendrou C.A., Attfield K.E., et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012, 488:508-511.
    • (2012) Nature , vol.488 , pp. 508-511
    • Gregory, A.P.1    Dendrou, C.A.2    Attfield, K.E.3
  • 55
    • 27944499757 scopus 로고    scopus 로고
    • Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
    • Haas J., Hug A., Viehover A., et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 2005, 35:3343-3352.
    • (2005) Eur J Immunol , vol.35 , pp. 3343-3352
    • Haas, J.1    Hug, A.2    Viehover, A.3
  • 57
    • 39049142995 scopus 로고    scopus 로고
    • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
    • Hauser S.L., Waubant E., Arnold D.L., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008, 358:676-688.
    • (2008) N Engl J Med , vol.358 , pp. 676-688
    • Hauser, S.L.1    Waubant, E.2    Arnold, D.L.3
  • 58
    • 70449418132 scopus 로고    scopus 로고
    • Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial
    • Hawker K., O'Connor P., Freedman M.S., et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009, 66:460-471.
    • (2009) Ann Neurol , vol.66 , pp. 460-471
    • Hawker, K.1    O'Connor, P.2    Freedman, M.S.3
  • 59
    • 0025218924 scopus 로고
    • VLA proteins in the integrin family: structures, functions, and their role on leukocytes
    • Hemler M.E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990, 8:365-400.
    • (1990) Annu Rev Immunol , vol.8 , pp. 365-400
    • Hemler, M.E.1
  • 60
    • 0023858086 scopus 로고
    • Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments
    • Higgins P.J., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988, 140:440-445.
    • (1988) J Immunol , vol.140 , pp. 440-445
    • Higgins, P.J.1    Weiner, H.L.2
  • 61
    • 0347785480 scopus 로고    scopus 로고
    • Control of regulatory T cell development by the transcription factor Foxp3
    • Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
    • (2003) Science , vol.299 , pp. 1057-1061
    • Hori, S.1    Nomura, T.2    Sakaguchi, S.3
  • 62
    • 56349101474 scopus 로고    scopus 로고
    • Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments
    • Huizinga R., Gerritsen W., Heijmans N., et al. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol Dis 2008, 32:461-470.
    • (2008) Neurobiol Dis , vol.32 , pp. 461-470
    • Huizinga, R.1    Gerritsen, W.2    Heijmans, N.3
  • 63
    • 0035801332 scopus 로고    scopus 로고
    • A pathogenic role for myelin-specific cd8(+) T cells in a model for multiple sclerosis
    • Huseby E.S., Liggitt D., Brabb T., et al. A pathogenic role for myelin-specific cd8(+) T cells in a model for multiple sclerosis. J Exp Med 2001, 194:669-676.
    • (2001) J Exp Med , vol.194 , pp. 669-676
    • Huseby, E.S.1    Liggitt, D.2    Brabb, T.3
  • 64
    • 0026647293 scopus 로고
    • Role of CD8+T cells in murine experimental allergic encephalomyelitis
    • Jiang H., Zhang S.I., Pernis B. Role of CD8+T cells in murine experimental allergic encephalomyelitis. Science 1992, 256:1213-1215.
    • (1992) Science , vol.256 , pp. 1213-1215
    • Jiang, H.1    Zhang, S.I.2    Pernis, B.3
  • 65
    • 0029082566 scopus 로고
    • Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial The Copolymer 1 Multiple Sclerosis Study Group
    • Johnson K.P., Brooks B.R., Cohen J.A., et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial The Copolymer 1 Multiple Sclerosis Study Group. Neurology 1995, 45:1268-1276.
    • (1995) Neurology , vol.45 , pp. 1268-1276
    • Johnson, K.P.1    Brooks, B.R.2    Cohen, J.A.3
  • 66
    • 11144357311 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship
    • Jonsson S., Andersson G., Fex T., et al. Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship. J Med Chem 2004, 47:2075-2088.
    • (2004) J Med Chem , vol.47 , pp. 2075-2088
    • Jonsson, S.1    Andersson, G.2    Fex, T.3
  • 67
    • 0002481864 scopus 로고
    • A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases
    • Kabat E.A., Freedman D.A. A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases. Am J Med Sci 1950, 219:55-64.
    • (1950) Am J Med Sci , vol.219 , pp. 55-64
    • Kabat, E.A.1    Freedman, D.A.2
  • 68
    • 81555202418 scopus 로고    scopus 로고
    • Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
    • Kappos L., Li D., Calabresi P.A., et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 2011, 378:1779-1787.
    • (2011) Lancet , vol.378 , pp. 1779-1787
    • Kappos, L.1    Li, D.2    Calabresi, P.A.3
  • 69
    • 0026604243 scopus 로고
    • Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation
    • Karussis D.M., Slavin S., Lehmann D., et al. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992, 148:1693-1698.
    • (1992) J Immunol , vol.148 , pp. 1693-1698
    • Karussis, D.M.1    Slavin, S.2    Lehmann, D.3
  • 70
    • 0027496152 scopus 로고
    • Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide
    • Karussis D.M., Lehmann D., Slavin S., et al. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol 1993, 34:654-660.
    • (1993) Ann Neurol , vol.34 , pp. 654-660
    • Karussis, D.M.1    Lehmann, D.2    Slavin, S.3
  • 71
    • 0027197490 scopus 로고
    • Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)
    • Karussis D.M., Lehmann D., Slavin S., et al. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A 1993, 90:6400-6404.
    • (1993) Proc Natl Acad Sci U S A , vol.90 , pp. 6400-6404
    • Karussis, D.M.1    Lehmann, D.2    Slavin, S.3
  • 72
    • 33645283403 scopus 로고    scopus 로고
    • FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration
    • Kataoka H., Sugahara K., Shimano K., et al. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell Mol Immunol 2005, 2:439-448.
    • (2005) Cell Mol Immunol , vol.2 , pp. 439-448
    • Kataoka, H.1    Sugahara, K.2    Shimano, K.3
  • 73
    • 34948909646 scopus 로고    scopus 로고
    • Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
    • Kebir H., Kreymborg K., Ifergan I., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173-1175.
    • (2007) Nat Med , vol.13 , pp. 1173-1175
    • Kebir, H.1    Kreymborg, K.2    Ifergan, I.3
  • 74
    • 0031570934 scopus 로고    scopus 로고
    • Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis -A comparison between oral and peripheral tolerance
    • Kennedy K.J., Smith W.S., Miller S.D., et al. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis -A comparison between oral and peripheral tolerance. J Immunol 1997, 159:1036-1044.
    • (1997) J Immunol , vol.159 , pp. 1036-1044
    • Kennedy, K.J.1    Smith, W.S.2    Miller, S.D.3
  • 75
    • 0037311259 scopus 로고    scopus 로고
    • Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis
    • Kennel De March A., De Bouwerie M., Kolopp-Sarda M.N., et al. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J Neuroimmunol 2003, 135:117-125.
    • (2003) J Neuroimmunol , vol.135 , pp. 117-125
    • Kennel De March, A.1    De Bouwerie, M.2    Kolopp-Sarda, M.N.3
  • 76
    • 0026694021 scopus 로고
    • Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice
    • Koh D.R., Fung-Leung W.P., Ho A., et al. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice. Science 1992, 256:1210-1213.
    • (1992) Science , vol.256 , pp. 1210-1213
    • Koh, D.R.1    Fung-Leung, W.P.2    Ho, A.3
  • 78
    • 34147128572 scopus 로고    scopus 로고
    • Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
    • Korn T., Reddy J., Gao W., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007, 13:423-431.
    • (2007) Nat Med , vol.13 , pp. 423-431
    • Korn, T.1    Reddy, J.2    Gao, W.3
  • 79
    • 0032887020 scopus 로고    scopus 로고
    • Axonal pathology in multiple sclerosis A historical note
    • Kornek B., Lassmann H. Axonal pathology in multiple sclerosis A historical note. Brain Pathol 1999, 9:651-656.
    • (1999) Brain Pathol , vol.9 , pp. 651-656
    • Kornek, B.1    Lassmann, H.2
  • 80
    • 0033870097 scopus 로고    scopus 로고
    • Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
    • Kornek B., Storch M.K., Weissert R., et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000, 157:267-276.
    • (2000) Am J Pathol , vol.157 , pp. 267-276
    • Kornek, B.1    Storch, M.K.2    Weissert, R.3
  • 81
    • 46949104323 scopus 로고    scopus 로고
    • IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
    • Kroenke M.A., Carlson T.J., Andjelkovic A.V., et al. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008, 205:1535-1541.
    • (2008) J Exp Med , vol.205 , pp. 1535-1541
    • Kroenke, M.A.1    Carlson, T.J.2    Andjelkovic, A.V.3
  • 82
    • 33847677762 scopus 로고    scopus 로고
    • Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
    • Kuhle J., Lindberg R.L., Regeniter A., et al. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. J Neurol 2007, 254:160-168.
    • (2007) J Neurol , vol.254 , pp. 160-168
    • Kuhle, J.1    Lindberg, R.L.2    Regeniter, A.3
  • 83
    • 0036788406 scopus 로고    scopus 로고
    • Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
    • Kuhlmann T., Lingfeld G., Bitsch A., et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002, 125:2202-2212.
    • (2002) Brain , vol.125 , pp. 2202-2212
    • Kuhlmann, T.1    Lingfeld, G.2    Bitsch, A.3
  • 84
    • 33751113922 scopus 로고    scopus 로고
    • CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
    • Kumar M., Putzki N., Limmroth V., et al. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J Neuroimmunol 2006, 180:178-184.
    • (2006) J Neuroimmunol , vol.180 , pp. 178-184
    • Kumar, M.1    Putzki, N.2    Limmroth, V.3
  • 85
    • 27644552194 scopus 로고    scopus 로고
    • Cortical demyelination and diffuse white matter injury in multiple sclerosis
    • Kutzelnigg A., Lucchinetti C.F., Stadelmann C., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
    • (2005) Brain , vol.128 , pp. 2705-2712
    • Kutzelnigg, A.1    Lucchinetti, C.F.2    Stadelmann, C.3
  • 86
    • 0028102655 scopus 로고
    • High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
    • Lafaille J.J., Nagashima K., Katsuki M., et al. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994, 78:399-408.
    • (1994) Cell , vol.78 , pp. 399-408
    • Lafaille, J.J.1    Nagashima, K.2    Katsuki, M.3
  • 87
    • 13244283212 scopus 로고    scopus 로고
    • IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
    • Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
    • (2005) J Exp Med , vol.201 , pp. 233-240
    • Langrish, C.L.1    Chen, Y.2    Blumenschein, W.M.3
  • 88
    • 58149251898 scopus 로고    scopus 로고
    • Late developmental plasticity in the T helper 17 lineage
    • Lee Y.K., Turner H., Maynard C.L., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
    • (2009) Immunity , vol.30 , pp. 92-107
    • Lee, Y.K.1    Turner, H.2    Maynard, C.L.3
  • 89
    • 58149159798 scopus 로고    scopus 로고
    • Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis
    • Lees J.R., Golumbek P.T., Sim J., et al. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J Exp Med 2008, 205:2633-2642.
    • (2008) J Exp Med , vol.205 , pp. 2633-2642
    • Lees, J.R.1    Golumbek, P.T.2    Sim, J.3
  • 90
    • 0026664422 scopus 로고
    • Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
    • Lehmann P.V., Forsthuber T., Miller A., et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157.
    • (1992) Nature , vol.358 , pp. 155-157
    • Lehmann, P.V.1    Forsthuber, T.2    Miller, A.3
  • 91
    • 33947265597 scopus 로고    scopus 로고
    • Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1
    • Lehmann J.C., Listopad J.J., Rentzsch C.U., et al. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 2007, 127:835-845.
    • (2007) J Invest Dermatol , vol.127 , pp. 835-845
    • Lehmann, J.C.1    Listopad, J.J.2    Rentzsch, C.U.3
  • 92
    • 0033546665 scopus 로고    scopus 로고
    • TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study
    • Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group
    • Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999, 53:457-465.
    • (1999) Neurology , vol.53 , pp. 457-465
  • 93
    • 0033566933 scopus 로고    scopus 로고
    • Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis
    • Lenz D.C., Wolf N.A., Swanborg R.H. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. J Immunol 1999, 163:1763-1768.
    • (1999) J Immunol , vol.163 , pp. 1763-1768
    • Lenz, D.C.1    Wolf, N.A.2    Swanborg, R.H.3
  • 94
    • 77957759539 scopus 로고    scopus 로고
    • Characterization of brain lesions in a mouse model of progressive multiple sclerosis
    • Levy H., Assaf Y., Frenkel D. Characterization of brain lesions in a mouse model of progressive multiple sclerosis. Exp Neurol 2010, 226:148-158.
    • (2010) Exp Neurol , vol.226 , pp. 148-158
    • Levy, H.1    Assaf, Y.2    Frenkel, D.3
  • 95
    • 0023931606 scopus 로고
    • Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
    • Linington C., Bradl M., Lassmann H., et al. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988, 130:443-454.
    • (1988) Am J Pathol , vol.130 , pp. 443-454
    • Linington, C.1    Bradl, M.2    Lassmann, H.3
  • 96
    • 20444394379 scopus 로고    scopus 로고
    • Mechanisms of axonal degeneration in EAE - lessons from CNTF and MHC I knockout mice
    • Linker R.A., Sendtner M., Gold R. Mechanisms of axonal degeneration in EAE - lessons from CNTF and MHC I knockout mice. J Neurol Sci 2005, 233:167-172.
    • (2005) J Neurol Sci , vol.233 , pp. 167-172
    • Linker, R.A.1    Sendtner, M.2    Gold, R.3
  • 97
    • 0031916192 scopus 로고    scopus 로고
    • TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
    • Liu J., Marino M.W., Wong G., et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998, 4:78-83.
    • (1998) Nat Med , vol.4 , pp. 78-83
    • Liu, J.1    Marino, M.W.2    Wong, G.3
  • 98
    • 33646029748 scopus 로고    scopus 로고
    • Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis
    • Liu L., Huang D., Matsui M., et al. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. J Immunol 2006, 176:4399-4409.
    • (2006) J Immunol , vol.176 , pp. 4399-4409
    • Liu, L.1    Huang, D.2    Matsui, M.3
  • 99
    • 33646596928 scopus 로고    scopus 로고
    • Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE
    • Liu Y., Teige I., Birnir B., et al. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006, 12:518-525.
    • (2006) Nat Med , vol.12 , pp. 518-525
    • Liu, Y.1    Teige, I.2    Birnir, B.3
  • 100
    • 0036105484 scopus 로고    scopus 로고
    • Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
    • Lock C., Hermans G., Pedotti R., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508.
    • (2002) Nat Med , vol.8 , pp. 500-508
    • Lock, C.1    Hermans, G.2    Pedotti, R.3
  • 101
    • 42249084849 scopus 로고    scopus 로고
    • Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
    • Luger D., Silver P.B., Tang J., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
    • (2008) J Exp Med , vol.205 , pp. 799-810
    • Luger, D.1    Silver, P.B.2    Tang, J.3
  • 102
    • 84880559839 scopus 로고    scopus 로고
    • Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis
    • Lutterotti A., Yusef S., Sputtek A., et al. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci Transl Med 2013, 5:188ra75.
    • (2013) Sci Transl Med , vol.5
    • Lutterotti, A.1    Yusef, S.2    Sputtek, A.3
  • 103
    • 0032729174 scopus 로고    scopus 로고
    • B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide
    • Lyons J.A., San M., Happ M.P., et al. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 1999, 29:3432-3439.
    • (1999) Eur J Immunol , vol.29 , pp. 3432-3439
    • Lyons, J.A.1    San, M.2    Happ, M.P.3
  • 104
    • 1242340285 scopus 로고    scopus 로고
    • Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis
    • Magliozzi R., Columba-Cabezas S., Serafini B., et al. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 2004, 148:11-23.
    • (2004) J Neuroimmunol , vol.148 , pp. 11-23
    • Magliozzi, R.1    Columba-Cabezas, S.2    Serafini, B.3
  • 105
    • 0028306935 scopus 로고
    • Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats
    • Malotky M.K.H., Pope L., Miller S.D. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats. J Immunol 1994, 153:841-851.
    • (1994) J Immunol , vol.153 , pp. 841-851
    • Malotky, M.K.H.1    Pope, L.2    Miller, S.D.3
  • 106
    • 49949093283 scopus 로고    scopus 로고
    • Autologous haematopoietic stem-cell transplantation in multiple sclerosis
    • Mancardi G., Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 2008, 7:626-636.
    • (2008) Lancet Neurol , vol.7 , pp. 626-636
    • Mancardi, G.1    Saccardi, R.2
  • 107
    • 11144358095 scopus 로고    scopus 로고
    • Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association
    • Mantegazza R., Cristaldini P., Bernasconi P., et al. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. Int Immunol 2004, 16:559-565.
    • (2004) Int Immunol , vol.16 , pp. 559-565
    • Mantegazza, R.1    Cristaldini, P.2    Bernasconi, P.3
  • 108
    • 77951723662 scopus 로고    scopus 로고
    • Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population
    • Marquardt N., Wilk E., Pokoyski C., et al. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population. Eur J Immunol 2010, 40:1428-1439.
    • (2010) Eur J Immunol , vol.40 , pp. 1428-1439
    • Marquardt, N.1    Wilk, E.2    Pokoyski, C.3
  • 109
    • 34948864286 scopus 로고    scopus 로고
    • Neurofascin as a novel target for autoantibody-mediated axonal injury
    • Mathey E.K., Derfuss T., Storch M.K., et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007, 204:2363-2372.
    • (2007) J Exp Med , vol.204 , pp. 2363-2372
    • Mathey, E.K.1    Derfuss, T.2    Storch, M.K.3
  • 110
    • 1642580757 scopus 로고    scopus 로고
    • Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
    • Matloubian M., Lo C.G., Cinamon G., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
    • (2004) Nature , vol.427 , pp. 355-360
    • Matloubian, M.1    Lo, C.G.2    Cinamon, G.3
  • 111
    • 54949141219 scopus 로고    scopus 로고
    • Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
    • Matsushita T., Yanaba K., Bouaziz J.D., et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420-3430.
    • (2008) J Clin Invest , vol.118 , pp. 3420-3430
    • Matsushita, T.1    Yanaba, K.2    Bouaziz, J.D.3
  • 112
    • 0344389016 scopus 로고    scopus 로고
    • Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
    • Matusevicius D., Kivisakk P., He B., et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999, 5:101-104.
    • (1999) Mult Scler , vol.5 , pp. 101-104
    • Matusevicius, D.1    Kivisakk, P.2    He, B.3
  • 113
    • 0023628580 scopus 로고
    • T cell subsets in multiple sclerosis Gradients at plaque borders and differences in nonplaque regions
    • McCallum K., Esiri M.M., Tourtellotte W.W., et al. T cell subsets in multiple sclerosis Gradients at plaque borders and differences in nonplaque regions. Brain 1987, 110:1297-1308.
    • (1987) Brain , vol.110 , pp. 1297-1308
    • McCallum, K.1    Esiri, M.M.2    Tourtellotte, W.W.3
  • 114
    • 60749107176 scopus 로고    scopus 로고
    • The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo
    • McGeachy M.J., Chen Y., Tato C.M., et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 2009, 10:314-324.
    • (2009) Nat Immunol , vol.10 , pp. 314-324
    • McGeachy, M.J.1    Chen, Y.2    Tato, C.M.3
  • 115
    • 50349102854 scopus 로고    scopus 로고
    • B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases
    • McLaughlin K.A., Wucherpfennig K.W. B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol 2008, 98:121-149.
    • (2008) Adv Immunol , vol.98 , pp. 121-149
    • McLaughlin, K.A.1    Wucherpfennig, K.W.2
  • 116
    • 16244417773 scopus 로고    scopus 로고
    • Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
    • McMahon E.J., Bailey S.L., Castenada C.V., et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005, 11:335-339.
    • (2005) Nat Med , vol.11 , pp. 335-339
    • McMahon, E.J.1    Bailey, S.L.2    Castenada, C.V.3
  • 117
    • 0029000750 scopus 로고
    • Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis
    • McRae B.L., Vanderlugt C.L., Dal Canto M.C., et al. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995, 182:75-85.
    • (1995) J Exp Med , vol.182 , pp. 75-85
    • McRae, B.L.1    Vanderlugt, C.L.2    Dal Canto, M.C.3
  • 118
    • 0026601932 scopus 로고
    • Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10PL mice
    • Merrill J.E., Kono D.H., Clayton J., et al. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10PL mice. Proc Natl Acad Sci U S A 1992, 89:574-578.
    • (1992) Proc Natl Acad Sci U S A , vol.89 , pp. 574-578
    • Merrill, J.E.1    Kono, D.H.2    Clayton, J.3
  • 119
    • 0030293682 scopus 로고    scopus 로고
    • Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
    • Meyer A.L., Benson J.M., Gienapp I.E., et al. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol 1996, 157:4230-4238.
    • (1996) J Immunol , vol.157 , pp. 4230-4238
    • Meyer, A.L.1    Benson, J.M.2    Gienapp, I.E.3
  • 120
    • 0018414685 scopus 로고
    • The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells
    • Miller S.D., Wetzig R.P., Claman H.N. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med 1979, 149:758-773.
    • (1979) J Exp Med , vol.149 , pp. 758-773
    • Miller, S.D.1    Wetzig, R.P.2    Claman, H.N.3
  • 121
    • 0026718660 scopus 로고
    • Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein V Hierarchy of suppression by myelin basic protein from different species
    • Miller A., Lider O., Al-Sabbagh A., et al. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein V Hierarchy of suppression by myelin basic protein from different species. J Neuroimmunol 1992, 39:243-250.
    • (1992) J Neuroimmunol , vol.39 , pp. 243-250
    • Miller, A.1    Lider, O.2    Al-Sabbagh, A.3
  • 122
    • 0037413467 scopus 로고    scopus 로고
    • A controlled trial of natalizumab for relapsing multiple sclerosis
    • Miller D.H., Khan O.A., Sheremata W.A., et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003, 348:15-23.
    • (2003) N Engl J Med , vol.348 , pp. 15-23
    • Miller, D.H.1    Khan, O.A.2    Sheremata, W.A.3
  • 123
    • 84864117759 scopus 로고    scopus 로고
    • Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod
    • Mishra M.K., Wang J., Silva C., et al. Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod. Am J Pathol 2012, 181:642-651.
    • (2012) Am J Pathol , vol.181 , pp. 642-651
    • Mishra, M.K.1    Wang, J.2    Silva, C.3
  • 124
    • 79951907091 scopus 로고    scopus 로고
    • Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis
    • Monson N.L., Cravens P., Hussain R., et al. Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. PLoS One 2011, 6:e17103.
    • (2011) PLoS One , vol.6
    • Monson, N.L.1    Cravens, P.2    Hussain, R.3
  • 125
    • 3242740010 scopus 로고    scopus 로고
    • Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies
    • Montero E., Nussbaum G., Kaye J.F., et al. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J Autoimmun 2004, 23:1-7.
    • (2004) J Autoimmun , vol.23 , pp. 1-7
    • Montero, E.1    Nussbaum, G.2    Kaye, J.F.3
  • 126
    • 0029869119 scopus 로고    scopus 로고
    • Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
    • Moreau T., Coles A., Wing M., et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996, 119:225-237.
    • (1996) Brain , vol.119 , pp. 225-237
    • Moreau, T.1    Coles, A.2    Wing, M.3
  • 127
    • 0022640843 scopus 로고
    • Two types of murine helper T cell clones I Definition according to profiles of lymphokine activities and secreted proteins
    • Mosmann T.R., Cherwinski H., Bond M.W., et al. Two types of murine helper T cell clones I Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
    • (1986) J Immunol , vol.136 , pp. 2348-2357
    • Mosmann, T.R.1    Cherwinski, H.2    Bond, M.W.3
  • 128
    • 0029079852 scopus 로고
    • Induction of MHC class I genes in neurons
    • Neumann H., Cavalie A., Jenne D.E., et al. Induction of MHC class I genes in neurons. Science 1995, 269:549-552.
    • (1995) Science , vol.269 , pp. 549-552
    • Neumann, H.1    Cavalie, A.2    Jenne, D.E.3
  • 129
    • 0034624942 scopus 로고    scopus 로고
    • Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results North American Linomide Investigators
    • Noseworthy J.H., Wolinsky J.S., Lublin F.D., et al. Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results North American Linomide Investigators. Neurology 2000, 54:1726-1733.
    • (2000) Neurology , vol.54 , pp. 1726-1733
    • Noseworthy, J.H.1    Wolinsky, J.S.2    Lublin, F.D.3
  • 130
    • 0031661686 scopus 로고    scopus 로고
    • The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network
    • Ockenfels H.M., Schultewolter T., Ockenfels G., et al. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998, 139:390-395.
    • (1998) Br J Dermatol , vol.139 , pp. 390-395
    • Ockenfels, H.M.1    Schultewolter, T.2    Ockenfels, G.3
  • 132
    • 0001158889 scopus 로고
    • Experimental disseminated encephalomyelitis in white mice
    • Olitsky P.K., Yager R.H. Experimental disseminated encephalomyelitis in white mice. J Exp Med 1949, 90:213-223.
    • (1949) J Exp Med , vol.90 , pp. 213-223
    • Olitsky, P.K.1    Yager, R.H.2
  • 133
    • 0032538918 scopus 로고    scopus 로고
    • Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis
    • Olivares-Villagomez D., Wang Y., Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 1998, 188:1883-1894.
    • (1998) J Exp Med , vol.188 , pp. 1883-1894
    • Olivares-Villagomez, D.1    Wang, Y.2    Lafaille, J.J.3
  • 134
    • 0023157207 scopus 로고
    • Role of the clotting system in the pathogenesis of neuroimmunologic disease
    • Paterson P.Y., Koh C.S., Kwaan H.C. Role of the clotting system in the pathogenesis of neuroimmunologic disease. Fed Proc 1987, 46:91-96.
    • (1987) Fed Proc , vol.46 , pp. 91-96
    • Paterson, P.Y.1    Koh, C.S.2    Kwaan, H.C.3
  • 135
    • 0030741166 scopus 로고    scopus 로고
    • Production of cytokines by human B cells in health and disease
    • Pistoia V. Production of cytokines by human B cells in health and disease. Immunol Today 1997, 18:343-350.
    • (1997) Immunol Today , vol.18 , pp. 343-350
    • Pistoia, V.1
  • 136
    • 33847669192 scopus 로고    scopus 로고
    • CD4+ CD25+[corrected] regulatory T cells render naive CD4+ CD25-T cells anergic and suppressive
    • Qiao M., Thornton A.M., Shevach E.M. CD4+ CD25+[corrected] regulatory T cells render naive CD4+ CD25-T cells anergic and suppressive. Immunology 2007, 120:447-455.
    • (2007) Immunology , vol.120 , pp. 447-455
    • Qiao, M.1    Thornton, A.M.2    Shevach, E.M.3
  • 137
    • 0030071366 scopus 로고    scopus 로고
    • Intravenous antigen administration as a therapy for autoimmune demyelinating disease
    • Racke M.K., Critchfield J.M., Quigley L., et al. Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann Neurol 1996, 39:46-56.
    • (1996) Ann Neurol , vol.39 , pp. 46-56
    • Racke, M.K.1    Critchfield, J.M.2    Quigley, L.3
  • 138
    • 65249175159 scopus 로고    scopus 로고
    • C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
    • Reboldi A., Coisne C., Baumjohann D., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009, 10:514-523.
    • (2009) Nat Immunol , vol.10 , pp. 514-523
    • Reboldi, A.1    Coisne, C.2    Baumjohann, D.3
  • 139
    • 0031439343 scopus 로고    scopus 로고
    • Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible
    • Redford E.J., Kapoor R., Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997, 120:2149-2157.
    • (1997) Brain , vol.120 , pp. 2149-2157
    • Redford, E.J.1    Kapoor, R.2    Smith, K.J.3
  • 140
    • 0030926207 scopus 로고    scopus 로고
    • Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans
    • Rep M.H., van Oosten B.W., Roos M.T., et al. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J Clin Invest 1997, 99:2225-2231.
    • (1997) J Clin Invest , vol.99 , pp. 2225-2231
    • Rep, M.H.1    van Oosten, B.W.2    Roos, M.T.3
  • 141
    • 2642698865 scopus 로고    scopus 로고
    • Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice
    • Riminton D.S., Korner H., Strickland D.H., et al. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice. J Exp Med 1998, 187:1517-1528.
    • (1998) J Exp Med , vol.187 , pp. 1517-1528
    • Riminton, D.S.1    Korner, H.2    Strickland, D.H.3
  • 142
    • 34548142973 scopus 로고    scopus 로고
    • Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results
    • Rose J.W., Burns J.B., Bjorklund J., et al. Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology 2007, 69:785-789.
    • (2007) Neurology , vol.69 , pp. 785-789
    • Rose, J.W.1    Burns, J.B.2    Bjorklund, J.3
  • 143
    • 0025000863 scopus 로고
    • An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
    • Ruddle N.H., Bergman C.M., McGrath K.M., et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 1990, 172:1193-1200.
    • (1990) J Exp Med , vol.172 , pp. 1193-1200
    • Ruddle, N.H.1    Bergman, C.M.2    McGrath, K.M.3
  • 144
    • 33745162188 scopus 로고    scopus 로고
    • Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
    • Schilling S., Goelz S., Linker R., et al. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol 2006, 145:101-107.
    • (2006) Clin Exp Immunol , vol.145 , pp. 101-107
    • Schilling, S.1    Goelz, S.2    Linker, R.3
  • 145
    • 84859151160 scopus 로고    scopus 로고
    • Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity
    • Schulze-Topphoff U., Shetty A., Varrin-Doyer M., et al. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One 2012, 7:e33797.
    • (2012) PLoS One , vol.7
    • Schulze-Topphoff, U.1    Shetty, A.2    Varrin-Doyer, M.3
  • 146
    • 48849087125 scopus 로고    scopus 로고
    • Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
    • Segal B.M., Constantinescu C.S., Raychaudhuri A., et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008, 7:796-804.
    • (2008) Lancet Neurol , vol.7 , pp. 796-804
    • Segal, B.M.1    Constantinescu, C.S.2    Raychaudhuri, A.3
  • 147
    • 0026094706 scopus 로고
    • Anti-tumor necrosis factor therapy abrogates autoimmune demyelination
    • Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991, 30:694-700.
    • (1991) Ann Neurol , vol.30 , pp. 694-700
    • Selmaj, K.1    Raine, C.S.2    Cross, A.H.3
  • 148
    • 2442708947 scopus 로고    scopus 로고
    • Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
    • Serafini B., Rosicarelli B., Magliozzi R., et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004, 14:164-174.
    • (2004) Brain Pathol , vol.14 , pp. 164-174
    • Serafini, B.1    Rosicarelli, B.2    Magliozzi, R.3
  • 149
    • 0024268211 scopus 로고
    • Increased diameter of demyelinated axons in chronic multiple sclerosis of the spinal cord
    • Shintaku M., Hirano A., Llena J.F. Increased diameter of demyelinated axons in chronic multiple sclerosis of the spinal cord. Neuropathol Appl Neurobiol 1988, 14:505-510.
    • (1988) Neuropathol Appl Neurobiol , vol.14 , pp. 505-510
    • Shintaku, M.1    Hirano, A.2    Llena, J.F.3
  • 150
    • 33645289121 scopus 로고    scopus 로고
    • CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs
    • Shiow L.R., Rosen D.B., Brdickova N., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.
    • (2006) Nature , vol.440 , pp. 540-544
    • Shiow, L.R.1    Rosen, D.B.2    Brdickova, N.3
  • 151
    • 77957056123 scopus 로고    scopus 로고
    • In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis
    • Siffrin V., Radbruch H., Glumm R., et al. In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 2010, 33:424-436.
    • (2010) Immunity , vol.33 , pp. 424-436
    • Siffrin, V.1    Radbruch, H.2    Glumm, R.3
  • 152
    • 0034991196 scopus 로고    scopus 로고
    • Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes
    • Slavin A.J., Maron R., Weiner H.L. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol 2001, 13:825-833.
    • (2001) Int Immunol , vol.13 , pp. 825-833
    • Slavin, A.J.1    Maron, R.2    Weiner, H.L.3
  • 153
    • 0035067635 scopus 로고    scopus 로고
    • Electrically active axons degenerate when exposed to nitric oxide
    • Smith K.J., Kapoor R., Hall S.M., et al. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001, 49:470-476.
    • (2001) Ann Neurol , vol.49 , pp. 470-476
    • Smith, K.J.1    Kapoor, R.2    Hall, S.M.3
  • 154
    • 22144479728 scopus 로고    scopus 로고
    • Differential induction of IgE-mediated anaphylaxis after soluble vs cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis
    • Smith C.E., Eagar T.N., Strominger J.L., et al. Differential induction of IgE-mediated anaphylaxis after soluble vs cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2005, 102:9595-9600.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 9595-9600
    • Smith, C.E.1    Eagar, T.N.2    Strominger, J.L.3
  • 155
    • 28544450761 scopus 로고    scopus 로고
    • Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis
    • Sriram S., Steiner I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 2005, 58:939-945.
    • (2005) Ann Neurol , vol.58 , pp. 939-945
    • Sriram, S.1    Steiner, I.2
  • 156
    • 0019978208 scopus 로고
    • Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions
    • Sriram S., Solomon D., Rouse R.V., et al. Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions. J Immunol 1982, 129:1649-1651.
    • (1982) J Immunol , vol.129 , pp. 1649-1651
    • Sriram, S.1    Solomon, D.2    Rouse, R.V.3
  • 157
    • 0020549560 scopus 로고
    • Administration of myelin basic protein-coupled spleen cells prevents experimental allergic encephalitis
    • Sriram S., Schwartz G., Steinman L. Administration of myelin basic protein-coupled spleen cells prevents experimental allergic encephalitis. Cell Immunol 1983, 75:378-382.
    • (1983) Cell Immunol , vol.75 , pp. 378-382
    • Sriram, S.1    Schwartz, G.2    Steinman, L.3
  • 158
    • 0033168629 scopus 로고    scopus 로고
    • Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response
    • Stefferl A., Brehm U., Storch M., et al. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol 1999, 163:40-49.
    • (1999) J Immunol , vol.163 , pp. 40-49
    • Stefferl, A.1    Brehm, U.2    Storch, M.3
  • 159
    • 40449089827 scopus 로고    scopus 로고
    • Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells
    • Stromnes I.M., Cerretti L.M., Liggitt D., et al. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 2008, 14:337-342.
    • (2008) Nat Med , vol.14 , pp. 337-342
    • Stromnes, I.M.1    Cerretti, L.M.2    Liggitt, D.3
  • 160
    • 0035877190 scopus 로고    scopus 로고
    • Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice
    • Sun D., Whitaker J.N., Huang Z., et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001, 166:7579-7587.
    • (2001) J Immunol , vol.166 , pp. 7579-7587
    • Sun, D.1    Whitaker, J.N.2    Huang, Z.3
  • 161
    • 0036318944 scopus 로고    scopus 로고
    • A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination
    • Svensson L., Abdul-Majid K.B., Bauer J., et al. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur J Immunol 2002, 32:1939-1946.
    • (2002) Eur J Immunol , vol.32 , pp. 1939-1946
    • Svensson, L.1    Abdul-Majid, K.B.2    Bauer, J.3
  • 162
    • 0035707638 scopus 로고    scopus 로고
    • Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity
    • Swanborg R.H. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol Rev 2001, 184:129-135.
    • (2001) Immunol Rev , vol.184 , pp. 129-135
    • Swanborg, R.H.1
  • 163
    • 0015103005 scopus 로고
    • Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide
    • Teitelbaum D., Meshorer A., Hirshfeld T., et al. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol 1971, 1:242-248.
    • (1971) Eur J Immunol , vol.1 , pp. 242-248
    • Teitelbaum, D.1    Meshorer, A.2    Hirshfeld, T.3
  • 164
    • 0016290415 scopus 로고
    • Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer
    • Teitelbaum D., Webb C., Bree M., et al. Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer. Clin Immunol Immunopathol 1974, 3:256-262.
    • (1974) Clin Immunol Immunopathol , vol.3 , pp. 256-262
    • Teitelbaum, D.1    Webb, C.2    Bree, M.3
  • 165
    • 0029916716 scopus 로고    scopus 로고
    • Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses
    • Teitelbaum D., Fridkis-Hareli M., Arnon R., et al. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses. J Neuroimmunol 1996, 64:209-217.
    • (1996) J Neuroimmunol , vol.64 , pp. 209-217
    • Teitelbaum, D.1    Fridkis-Hareli, M.2    Arnon, R.3
  • 166
    • 11144297111 scopus 로고    scopus 로고
    • Biological markers in CSF and blood for axonal degeneration in multiple sclerosis
    • Teunissen C.E., Dijkstra C., Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol 2005, 4:32-41.
    • (2005) Lancet Neurol , vol.4 , pp. 32-41
    • Teunissen, C.E.1    Dijkstra, C.2    Polman, C.3
  • 167
    • 83555174399 scopus 로고    scopus 로고
    • Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor
    • Thone J., Ellrichmann G., Seubert S., et al. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor. Am J Pathol 2012, 180:267-274.
    • (2012) Am J Pathol , vol.180 , pp. 267-274
    • Thone, J.1    Ellrichmann, G.2    Seubert, S.3
  • 168
    • 0034026891 scopus 로고    scopus 로고
    • Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor
    • Tran E.H., Kuziel W.A., Owens T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor. Eur J Immunol 2000, 30:1410-1415.
    • (2000) Eur J Immunol , vol.30 , pp. 1410-1415
    • Tran, E.H.1    Kuziel, W.A.2    Owens, T.3
  • 169
    • 0030899404 scopus 로고    scopus 로고
    • Diversity and plasticity of self recognition during the development of multiple sclerosis
    • Tuohy V.K., Yu M., Weinstock-Guttman B., et al. Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 1997, 99:1682-1690.
    • (1997) J Clin Invest , vol.99 , pp. 1682-1690
    • Tuohy, V.K.1    Yu, M.2    Weinstock-Guttman, B.3
  • 170
    • 33846919872 scopus 로고    scopus 로고
    • Peripheral tolerance Induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis
    • Turley D.M., Miller S.D. Peripheral tolerance Induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J Immunol 2007, 178:2212-2220.
    • (2007) J Immunol , vol.178 , pp. 2212-2220
    • Turley, D.M.1    Miller, S.D.2
  • 171
    • 33744936550 scopus 로고    scopus 로고
    • IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production
    • Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 2006, 176:7768-7774.
    • (2006) J Immunol , vol.176 , pp. 7768-7774
    • Vaknin-Dembinsky, A.1    Balashov, K.2    Weiner, H.L.3
  • 172
    • 0030880011 scopus 로고    scopus 로고
    • Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial
    • van Oosten B.W., Lai M., Hodgkinson S., et al. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 1997, 49:351-357.
    • (1997) Neurology , vol.49 , pp. 351-357
    • van Oosten, B.W.1    Lai, M.2    Hodgkinson, S.3
  • 173
    • 17344363488 scopus 로고    scopus 로고
    • The functional significance of epitope spreading and its regulation by co-stimulatory molecules
    • Vanderlugt C.L., Begolka W.S., Neville K.L., et al. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev 1998, 164:63-72.
    • (1998) Immunol Rev , vol.164 , pp. 63-72
    • Vanderlugt, C.L.1    Begolka, W.S.2    Neville, K.L.3
  • 174
    • 33744904725 scopus 로고    scopus 로고
    • Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression
    • Venken K., Hellings N., Hensen K., et al. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J Neurosci Res 2006, 83:1432-1446.
    • (2006) J Neurosci Res , vol.83 , pp. 1432-1446
    • Venken, K.1    Hellings, N.2    Hensen, K.3
  • 175
    • 1842732224 scopus 로고    scopus 로고
    • Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
    • Viglietta V., Baecher-Allan C., Weiner H.L., et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004, 199:971-979.
    • (2004) J Exp Med , vol.199 , pp. 971-979
    • Viglietta, V.1    Baecher-Allan, C.2    Weiner, H.L.3
  • 176
    • 0037066132 scopus 로고    scopus 로고
    • Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS
    • Villar L.M., Masjuan J., Gonzalez-Porque P., et al. Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS. Neurology 2002, 58:824-826.
    • (2002) Neurology , vol.58 , pp. 824-826
    • Villar, L.M.1    Masjuan, J.2    Gonzalez-Porque, P.3
  • 177
    • 0021913219 scopus 로고
    • Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker
    • Waldor M.K., Sriram S., Hardy R., et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 1985, 227:415-417.
    • (1985) Science , vol.227 , pp. 415-417
    • Waldor, M.K.1    Sriram, S.2    Hardy, R.3
  • 178
    • 77955031189 scopus 로고    scopus 로고
    • Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?
    • Warnke C., Menge T., Hartung H.P., et al. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?. Arch Neurol 2010, 67:923-930.
    • (2010) Arch Neurol , vol.67 , pp. 923-930
    • Warnke, C.1    Menge, T.2    Hartung, H.P.3
  • 179
    • 0027467163 scopus 로고
    • Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue
    • Warren K.G., Catz I. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue. J Neurol Sci 1993, 115:169-176.
    • (1993) J Neurol Sci , vol.115 , pp. 169-176
    • Warren, K.G.1    Catz, I.2
  • 180
    • 3242683494 scopus 로고    scopus 로고
    • Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
    • Webb M., Tham C.S., Lin F.F., et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol 2004, 153:108-121.
    • (2004) J Neuroimmunol , vol.153 , pp. 108-121
    • Webb, M.1    Tham, C.S.2    Lin, F.F.3
  • 181
    • 77956360533 scopus 로고    scopus 로고
    • B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
    • Weber M.S., Prod'homme T., Patarroyo J.C., et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 2010, 68:369-383.
    • (2010) Ann Neurol , vol.68 , pp. 369-383
    • Weber, M.S.1    Prod'homme, T.2    Patarroyo, J.C.3
  • 182
    • 77956649428 scopus 로고    scopus 로고
    • Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
    • Wegner C., Stadelmann C., Pfortner R., et al. Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 2010, 227:133-143.
    • (2010) J Neuroimmunol , vol.227 , pp. 133-143
    • Wegner, C.1    Stadelmann, C.2    Pfortner, R.3
  • 183
    • 14544294320 scopus 로고    scopus 로고
    • Current issues in the treatment of human diseases by mucosal tolerance
    • Weiner H.L. Current issues in the treatment of human diseases by mucosal tolerance. Ann N Y Acad Sci 2004, 1029:211-224.
    • (2004) Ann N Y Acad Sci , vol.1029 , pp. 211-224
    • Weiner, H.L.1
  • 184
    • 0026042008 scopus 로고
    • Oral tolerance in experimental autoimmune encephalomyelitis: III Evidence for clonal anergy
    • Whitacre C.C., Gienapp I.E., Orosz C.G., et al. Oral tolerance in experimental autoimmune encephalomyelitis: III Evidence for clonal anergy. J Immunol 1991, 147:2155-2163.
    • (1991) J Immunol , vol.147 , pp. 2155-2163
    • Whitacre, C.C.1    Gienapp, I.E.2    Orosz, C.G.3
  • 185
    • 0030587910 scopus 로고    scopus 로고
    • IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
    • Willenborg D.O., Fordham S., Bernard C.C., et al. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996, 157:3223-3227.
    • (1996) J Immunol , vol.157 , pp. 3223-3227
    • Willenborg, D.O.1    Fordham, S.2    Bernard, C.C.3
  • 186
    • 0030456897 scopus 로고    scopus 로고
    • Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice
    • Wolf S.D., Dittel B.N., Hardardottir F., et al. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996, 184:2271-2278.
    • (1996) J Exp Med , vol.184 , pp. 2271-2278
    • Wolf, S.D.1    Dittel, B.N.2    Hardardottir, F.3
  • 187
    • 0030961031 scopus 로고    scopus 로고
    • Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients - Identity of key contact residues in the B-cell and T-cell epitopes
    • Wucherpfennig K.W., Catz I., Hausmann S., et al. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients - Identity of key contact residues in the B-cell and T-cell epitopes. J Clin Invest 1997, 100:1114-1122.
    • (1997) J Clin Invest , vol.100 , pp. 1114-1122
    • Wucherpfennig, K.W.1    Catz, I.2    Hausmann, S.3
  • 188
    • 4744340401 scopus 로고    scopus 로고
    • Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats
    • Yang J.S., Xu L.Y., Xiao B.G., et al. Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats. J Neuroimmunol 2004, 156:3-9.
    • (2004) J Neuroimmunol , vol.156 , pp. 3-9
    • Yang, J.S.1    Xu, L.Y.2    Xiao, B.G.3
  • 189
    • 0026506799 scopus 로고
    • Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin
    • Yednock T.A., Cannon C., Fritz L.C., et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992, 356:63-66.
    • (1992) Nature , vol.356 , pp. 63-66
    • Yednock, T.A.1    Cannon, C.2    Fritz, L.C.3
  • 190
    • 77953289016 scopus 로고    scopus 로고
    • Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis
    • York N.R., Mendoza J.P., Ortega S.B., et al. Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis. J Autoimmun 2010, 35:33-44.
    • (2010) J Autoimmun , vol.35 , pp. 33-44
    • York, N.R.1    Mendoza, J.P.2    Ortega, S.B.3
  • 191
    • 0029670711 scopus 로고    scopus 로고
    • Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis
    • Yu M., Nishiyama A., Trapp B.D., et al. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 1996, 64:91-100.
    • (1996) J Neuroimmunol , vol.64 , pp. 91-100
    • Yu, M.1    Nishiyama, A.2    Trapp, B.D.3
  • 192
    • 24344433564 scopus 로고    scopus 로고
    • Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions
    • Zhang Y., Da R.R., Hilgenberg L.G., et al. Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol 2005, 167:120-130.
    • (2005) J Neuroimmunol , vol.167 , pp. 120-130
    • Zhang, Y.1    Da, R.R.2    Hilgenberg, L.G.3
  • 193
    • 77953633327 scopus 로고    scopus 로고
    • TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis
    • Zhang H., Podojil J.R., Luo X., et al. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J Immunol 2010, 184:6629-6636.
    • (2010) J Immunol , vol.184 , pp. 6629-6636
    • Zhang, H.1    Podojil, J.R.2    Luo, X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.